Achieving and Maintaining Improved Quality of Life in Patients with Tardive Dyskinesia (HMP)

(609) 371-1137

Achieving and Maintaining Improved Quality of Life in Patients with Tardive Dyskinesia (HMP)

This On-Demand Webcast is intended for psychiatrists, primary care physicians, psychologists, physician assistants, psychiatric nurses, and other healthcare professionals who seek to improve the care of patients with mental health disorders.

LEARNING OBJECTIVES

After completing this activity, participants should be able to:

  • Outline the consequences of untreated TD on QoL in patients taking antipsychotic medications
  • Describe the clinical indications for and clinical benefits of administering the AIMS exam
  • Incorporate currently available data on the long-term efficacy and safety of VMAT2 inhibitors for the treatment of TD into clinical practice

Continuing Education Credits:

  • 0.75 APA
  • 0.75 CME
  • 0.75 CNE
  • 0.75 Participation